Bristol Myers Squibb (BMY) |
United States |
$146.464B |
10.44 |
CSL (CSLLY) |
Australia |
$96.318B |
0.00 |
Gilead Sciences (GILD) |
United States |
$77.142B |
10.26 |
Vertex Pharmaceuticals (VRTX) |
United States |
$59.055B |
27.46 |
Regeneron Pharmaceuticals (REGN) |
United States |
$54.623B |
19.38 |
Illumina (ILMN) |
United States |
$52.852B |
72.69 |
Moderna (MRNA) |
United States |
$49.092B |
0.00 |
Biogen (BIIB) |
United States |
$41.036B |
7.29 |
Alexion Pharmaceuticals (ALXN) |
United States |
$34.236B |
13.64 |
Seagen (SGEN) |
United States |
$31.962B |
84.14 |
BeiGene (BGNE) |
Cayman Islands |
$28.201B |
0.00 |
Genmab (GMAB) |
Denmark |
$28.073B |
33.20 |
Genmab (GNMSF) |
Denmark |
$26.488B |
6.10 |
BioNTech SE (BNTX) |
Germany |
$23.217B |
0.00 |
Exact Sciences (EXAS) |
United States |
$21.867B |
0.00 |
Incyte (INCY) |
United States |
$20.310B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$19.859B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$18.067B |
68.51 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$17.372B |
0.00 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$17.017B |
24.32 |
Guardant Health (GH) |
United States |
$15.932B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.875B |
98.72 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$13.803B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$12.974B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$12.763B |
81.63 |
QIAGEN (QGEN) |
Netherlands |
$12.146B |
27.35 |
Repligen (RGEN) |
United States |
$10.943B |
155.20 |
Mirati Therapeutics (MRTX) |
United States |
$10.155B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$9.884B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$9.138B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$8.840B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$8.684B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$8.475B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$8.223B |
0.00 |
Twist Bioscience (TWST) |
United States |
$8.187B |
0.00 |
Novavax (NVAX) |
United States |
$8.035B |
0.00 |
Exelixis (EXEL) |
United States |
$7.561B |
50.77 |
Acceleron Pharma (XLRN) |
United States |
$7.431B |
0.00 |
Sarepta Therapeutics (SRPT) |
United States |
$6.883B |
0.00 |
Galapagos (GLPG) |
Belgium |
$6.575B |
0.00 |
Halozyme Therapeutics (HALO) |
United States |
$6.101B |
282.06 |
Amicus Therapeutics (FOLD) |
United States |
$5.988B |
0.00 |
SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.964B |
17.44 |
NeoGenomics (NEO) |
United States |
$5.863B |
1760.33 |
Blueprint Medicines (BPMC) |
United States |
$5.794B |
19.18 |
Emergent Biosolutions (EBS) |
United States |
$5.705B |
18.72 |
Beam Therapeutics (BEAM) |
United States |
$5.677B |
0.00 |
Certara (CERT) |
United States |
$5.097B |
0.00 |
Eidos Therapeutics (EIDX) |
United States |
$4.702B |
0.00 |
China Biologic Products (CBPO) |
China |
$4.638B |
30.06 |
Editas Medicine (EDIT) |
United States |
$4.569B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$4.555B |
0.00 |
Vir Biotechnology (VIR) |
United States |
$4.529B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$4.491B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$4.118B |
0.00 |
Arvinas (ARVN) |
United States |
$3.990B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$3.751B |
135.76 |
Legend Biotech (LEGN) |
United States |
$3.709B |
0.00 |
Insmed (INSM) |
United States |
$3.706B |
0.00 |
Alkermes (ALKS) |
Ireland |
$3.473B |
34.09 |
Bluebird Bio (BLUE) |
United States |
$3.285B |
0.00 |
Global Blood Therapeutics (GBT) |
United States |
$3.031B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$2.940B |
0.00 |
I-Mab (IMAB) |
China |
$2.907B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$2.713B |
0.00 |
Zymeworks (ZYME) |
Canada |
$2.427B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$2.360B |
0.00 |
Amarin (AMRN) |
Ireland |
$2.331B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$2.316B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$2.192B |
0.00 |
ADC Therapeutics SA (ADCT) |
Switzerland |
$2.189B |
0.00 |
Viela Bio (VIE) |
United States |
$1.988B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$1.928B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$1.912B |
0.00 |
Genetron Holdings (GTH) |
China |
$1.878B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$1.867B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$1.849B |
15.30 |
Scholar Rock Holding (SRRK) |
United States |
$1.799B |
0.00 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.788B |
46.33 |
REGENXBIO (RGNX) |
United States |
$1.774B |
0.00 |
NGM Biopharmaceuticals (NGM) |
United States |
$1.774B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.768B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$1.746B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.692B |
0.00 |
Vericel (VCEL) |
United States |
$1.677B |
0.00 |
NantKwest (NK) |
United States |
$1.605B |
0.00 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.600B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$1.563B |
0.00 |
Precigen (PGEN) |
United States |
$1.562B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.493B |
0.00 |
Forma Therapeutics Holdings (FMTX) |
United States |
$1.477B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$1.474B |
0.00 |
Heska (HSKA) |
United States |
$1.441B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$1.439B |
0.00 |
Codexis (CDXS) |
United States |
$1.381B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$1.364B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$1.310B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.287B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$1.256B |
0.00 |
Cellectis S.A (CLLS) |
France |
$1.243B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.242B |
8.21 |
Alector (ALEC) |
United States |
$1.212B |
0.00 |
Mesoblast (MESO) |
Australia |
$1.192B |
0.00 |
Epizyme (EPZM) |
United States |
$1.171B |
0.00 |
Frequency Therapeutics (FREQ) |
United States |
$1.165B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$1.152B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$1.109B |
0.00 |
MiMedx (MDXG) |
United States |
$1.011B |
0.00 |
Athenex (ATNX) |
United States |
$0.997B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.987B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$0.983B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.979B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.957B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$0.943B |
0.00 |
Morphic Holding (MORF) |
United States |
$0.939B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.920B |
24.50 |
Compugen (CGEN) |
Israel |
$0.918B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.871B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$0.862B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.816B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$0.771B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.766B |
38.89 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.757B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.746B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.736B |
0.00 |
MannKind (MNKD) |
United States |
$0.735B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.707B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.695B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.688B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.653B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.651B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.643B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
Affimed (AFMD) |
Germany |
$0.636B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.628B |
0.00 |
Curis (CRIS) |
United States |
$0.620B |
0.00 |
Cardiff Oncology (CRDF) |
United States |
$0.619B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.618B |
0.00 |
Agenus (AGEN) |
United States |
$0.607B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$0.606B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.569B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.568B |
76.89 |
Dynavax Technologies (DVAX) |
United States |
$0.561B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.543B |
0.00 |
Aquinox Pharmaceuticals (NLTX) |
United States |
$0.541B |
0.00 |
Pandion Therapeutics (PAND) |
United States |
$0.540B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.535B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.525B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.514B |
0.00 |
Geron (GERN) |
United States |
$0.503B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.496B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.475B |
0.00 |
FORTE BIOSCIENC (FBRX) |
United States |
$0.469B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.467B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.465B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.460B |
0.00 |
Amryt Pharma (AMYT) |
United Kingdom |
$0.460B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.452B |
21.29 |
XOMA (XOMA) |
United States |
$0.446B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.445B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.437B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.432B |
0.00 |
AMMO (POWW) |
United States |
$0.431B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.429B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.424B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.421B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.415B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.410B |
0.00 |
Verastem (VSTM) |
United States |
$0.402B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.393B |
10.00 |
Athersys (ATHX) |
United States |
$0.384B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.383B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.379B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.371B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.362B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.355B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.351B |
0.00 |
Trevena (TRVN) |
United States |
$0.349B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.347B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.343B |
0.00 |
NextCure (NXTC) |
United States |
$0.333B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.324B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.321B |
8.24 |
Kamada (KMDA) |
Israel |
$0.314B |
14.71 |
Lineage Cell Therapeutics (LCTX) |
United States |
$0.306B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.303B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.284B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.277B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.265B |
0.00 |
IBio (IBIO) |
United States |
$0.262B |
0.00 |
HOOKIPA Pharma (HOOK) |
United States |
$0.236B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$0.232B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.231B |
0.00 |
Aptinyx (APTX) |
United States |
$0.230B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.218B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.212B |
0.00 |
Exicure (XCUR) |
United States |
$0.210B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.209B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.208B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.207B |
0.00 |
Cerecor (CERC) |
United States |
$0.205B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.205B |
0.00 |
TELA Bio (TELA) |
United States |
$0.202B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.199B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.198B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.198B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
VolitionRX (VNRX) |
United States |
$0.196B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.195B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.191B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.191B |
0.00 |
Nicox SA (NICXF) |
France |
$0.182B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.180B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.180B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.179B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.176B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.167B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.153B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.151B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.149B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.149B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.148B |
0.00 |
Dyadic (DYAI) |
United States |
$0.145B |
0.00 |
Evogene (EVGN) |
Israel |
$0.143B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.142B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.139B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.139B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.137B |
0.00 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.127B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.127B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.124B |
257.00 |
Ecology Coatings (ABVC) |
United States |
$0.123B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.122B |
0.00 |
Prometic Life Sciences (LMNL) |
Canada |
$0.119B |
0.00 |
AIT Therapeutics (XAIR) |
United States |
$0.118B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.117B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.116B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.112B |
0.00 |
Synlogic (SYBX) |
United States |
$0.111B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.105B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.102B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.102B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.101B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.099B |
0.00 |
Novogen (KZIA) |
Australia |
$0.096B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.090B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.090B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.088B |
0.00 |
MiRagen Therapeutics (MGEN) |
United States |
$0.087B |
0.00 |
Stealth BioTherapeutics (MITO) |
United States |
$0.081B |
38.75 |
CollPlant Holdings (CLGN) |
Israel |
$0.079B |
0.00 |
Seelos Therapeutics (SEEL) |
United States |
$0.077B |
0.00 |
CytRx (CYTR) |
United States |
$0.075B |
0.00 |
Adocia (ADOCY) |
France |
$0.074B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.069B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.067B |
0.00 |
AnPac Bio-Medical Science (ANPC) |
China |
$0.067B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.063B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.059B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.059B |
0.00 |
Happiness Biotech Group (HAPP) |
China |
$0.056B |
0.00 |
Yumanity Therapeutics (YMTX) |
United States |
$0.056B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.056B |
0.00 |
Appili Therapeutics (APLIF) |
Canada |
$0.055B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.054B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.052B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.051B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.049B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.049B |
0.00 |
Advaxis (ADXS) |
United States |
$0.045B |
0.00 |
BioCardia (BCDA) |
United States |
$0.045B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.044B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.043B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.043B |
0.00 |
Chanticleer Holdings (SONN) |
United States |
$0.042B |
0.00 |
Soligenix (SNGX) |
United States |
$0.042B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.040B |
0.00 |
Spherix (AIKI) |
United States |
$0.039B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.038B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.036B |
0.00 |
Celsion (CLSN) |
United States |
$0.034B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.031B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.029B |
0.00 |
Neuralstem (SNCA) |
United States |
$0.025B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
Cesca Therapeutics (THMO) |
United States |
$0.019B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.018B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.015B |
0.00 |
BioPharmX (TMBR) |
United States |
$0.014B |
0.00 |
CTD Holdings (CYTH) |
United States |
$0.009B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.008B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.004B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.000B |
0.00 |
Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |